Most popular ETFs | ||||||
iShares Core MSCI World UCITS ETF USD (Acc) | IE00B4L5Y983 | Equity | ETF | |||
Xtrackers MSCI Emerging Markets UCITS ETF 1C | IE00BTJRMP35 | Equity | ETF | |||
Vanguard FTSE All-World UCITS ETF Distributing | IE00B3RBWM25 | Equity | ETF | |||
iShares Global Clean Energy UCITS ETF USD (Dist) | IE00B1XNHC34 | Equity | ETF | |||
HSBC FTSE 100 UCITS ETF GBP | IE00B42TW061 | Equity | ETF |
Most popular categories |
Equity, World |
Equity, Dividend strategy |
Bonds, UK Gilts |
The iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) seeks to track the Nasdaq Biotechnology index. The Nasdaq Biotechnology index tracks Nasdaq listed companies primarily engaged in biomedical research to develop new treatments and cures for human disease.
Replication |
Physical (Optimized sampling) |
Legal structure | ETF |
Strategy risk | Long-only |
Fund currency | USD |
Currency risk |
Currency unhedged |
Volatility 1 year (in GBP) |
26.64%
![]() |
Inception/ Listing Date | 5 March 2018 |
Distribution policy | Distributing |
Distribution frequency | Semi annually |
Fund domicile | Ireland |
Fund Structure | Open-ended Investment Company (OEIC) |
UCITS compliance | Yes |
Fund Provider | iShares |
Administrator | State Street International Ireland Ltd |
Investment Advisor | |
Custodian Bank | State Street Custodial Services (Ireland) Limited |
Revision Company | Deloitte |
Fiscal Year End | 31 May |
Swiss representative | BlackRock Asset Management Schweiz AG |
Swiss paying agent | State Street Bank International GmbH, Munich, Zurich Branch |
Germany | 30% tax rebate |
Switzerland | ESTV Reporting |
Austria | Tax Reporting Fund |
UK | UK Reporting |
Indextype | Total return index |
Swap counterparty | - |
Collateral manager | Bank of New York Mellon|Euroclear|State Street Bank|JP Morgan |
Securities lending | Yes |
Securities lending counterparty | UBS AG|Deutsche Bank AG|Goldman Sachs International|BNP Paribas Arbitrage SNC|Merrill Lynch International|Citigroup Inc|BNP Paribas SA|Societe Generale SA|JP Morgan Chase & Co|The Bank of Nova Scotia|HSBC Bank Plc|Nomura International Plc|Macquarie Bank Limited|Credit Suisse Securities (Europe) Ltd.|Barclays Bank Plc|J.P. Morgan Securities Plc|Citigroup Global Markets Ltd|Morgan Stanley & Co. International Plc|Skandinaviska Enskilda Banken AB|Barclays Capital Securities Ltd. |
Below you find information about the composition of the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
AMGEN INC |
8.34%
|
REGENERON PHARMACEUTICALS INC |
8.30%
|
GILEAD SCIENCES INC |
8.09%
|
VERTEX PHARMACEUTICALS ORD |
7.63%
|
MODERNA INC |
5.42%
|
ASTRAZENECA PLC ADR |
3.97%
|
BIOGEN INC |
3.78%
|
SEAGEN INC ORD |
3.61%
|
ILLUMINA INC |
3.38%
|
HORIZON THERAPEUTICS PLC |
2.37%
|
United States |
82.65%
|
Ireland |
3.91%
|
Germany |
1.27%
|
Other |
12.17%
|
Health Care |
97.51%
|
Other |
2.49%
|
Current dividend yield | 0.45% |
Dividends (last 12 months) | GBP 0.02 |
Period | Dividend in GBP | Dividend yield in % |
---|---|---|
1 Year | GBP 0.02 | 0.52% |
2022 | GBP 0.02 | 0.43% |
2021 | GBP 0.01 | 0.25% |
2020 | GBP 0.01 | 0.22% |
2019 | GBP 0.01 | 0.17% |